These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10606084)

  • 1. Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy.
    Powderly WG; Gallant JE; Ghannoum MA; Mayer KH; Navarro EE; Perfect JR
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1619-23. PubMed ID: 10606084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment.
    Powderly WG; Mayer KH; Perfect JR
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1405-12. PubMed ID: 10555102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of oropharyngeal candidiasis in HIV-infected patients with oral amphotericin B suspension.
    Hood S; Evans J; Bond J; Wilkins E; Denning D
    AIDS Patient Care STDS; 1998 Aug; 12(8):625-7. PubMed ID: 15468434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
    Yang YL; Lo HJ; Hung CC; Li Y
    BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the management of oral candidiasis associated with HIV/AIDS.
    Albougy HA; Naidoo S
    SADJ; 2002 Dec; 57(11):457-66. PubMed ID: 12674866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Patton LL; Bonito AJ; Shugars DA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida infection in HIV positive patients 1985-2007.
    Traeder C; Kowoll S; Arastéh K
    Mycoses; 2008 Sep; 51 Suppl 2():58-61. PubMed ID: 18721333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease.
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748
    [No Abstract]   [Full Text] [Related]  

  • 11. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.
    Vazquez JA
    Pharmacotherapy; 1999 Jan; 19(1):76-87. PubMed ID: 9917080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
    Valdez H; Gripshover BM; Salata RA; Lederman MM
    AIDS; 1998 Mar; 12(5):538. PubMed ID: 9543458
    [No Abstract]   [Full Text] [Related]  

  • 13. Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
    Horn CA; Washburn RG; Givner LB; Peacock JE; Pegram PS
    AIDS; 1995 May; 9(5):533-4. PubMed ID: 7639986
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
    Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infections by Candida and cryptococci].
    Berenguer J; Blázquez R; Ocaña I; Lozano F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():29-35. PubMed ID: 9859617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection.
    Vazquez JA; Skiest DJ; Tissot-Dupont H; Lennox JL; Boparai N; Isaacs R
    HIV Clin Trials; 2007; 8(2):86-97. PubMed ID: 17507324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspergillus sinusitis in two HIV-infected men.
    Keller MJ; Sax PE
    AIDS Clin Care; 1997 Dec; 9(12):94, 100. PubMed ID: 11364841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
    Wu CJ; Lee HC; Yang YL; Chang CM; Chen HT; Lin CC; Lee NY; Chu WL; Hsieh LY; Wang YL; Lauderale TL; Tseng FC; Ko NY; Ko WC; Lo HJ
    Clin Microbiol Infect; 2012 May; 18(5):485-90. PubMed ID: 21939471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
    López-Dupla M; Mora Sanz P; Pintado García V; Valencia Ortega E; Uriol PL; Khamashta MA; Aguado AG
    Am J Gastroenterol; 1992 Dec; 87(12):1771-6. PubMed ID: 1449139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of azole-resistant oropharyngeal candidiasis with topical amphotericin B.
    Grim SA; Smith KM; Romanelli F; Ofotokun I
    Ann Pharmacother; 2002 Sep; 36(9):1383-6. PubMed ID: 12196056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.